Literature DB >> 11935095

Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors.

C Hellerbrand1, A Hartmann, G Richter, A Knöll, R Wiest, J Schölmerich, G Lock.   

Abstract

UNLABELLED: The aetiology of chronic liver disease leading to hepatocellular carcinoma (HCC) and the clinical characteristics of patients with HCC vary considerably internationally and intranationally. This study analyses the characteristics of HCC patients in southern Germany, a low endemic area of HCC.
METHODS: The files of 118 consecutive patients with HCC observed in a single tertiary care hospital between 1994 and 2000 have been reviewed. Epidemiological and clinicopathological characteristics such as age at presentation, ethanol consumption, serological hepatitis virus markers, and fibrosis were studied. Additionally, serum levels of alpha-fetoprotein (AFP) were analysed at the time of diagnosis in 77 patients.
RESULTS: The male:female ratio was 4:1 and the mean age at presentation was 61.8 years. Alcohol abuse (49.2%) and chronic hepatitis C infection (17.8%) were the most frequent risk factors. Histologically proven liver cirrhosis in the surrounding non-tumorous tissue was present in only 59.0% of cases. AFP levels were elevated in 78% of cases, but only 34% reached >500 ng/ml, a value considered to be significant for the diagnosis of HCC. AFP levels correlated with the stage of fibrosis. SUMMARY AND
CONCLUSIONS: The sensitivity of AFP serum levels as a tumour marker is poor but might help to detect at least a minority of cases. As in other populations within Europe, chronic alcohol abuse is frequently associated with HCC in southern Germany, confirming that alcohol is still the most important risk factor for hepatocarcinogenesis in areas with low hepatitis virus prevalence. Considering the poor prognosis of HCC, prevention is of pivotal importance, particularly for patients with chronic liver disease and other risk factors for the development of HCC. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11935095     DOI: 10.1159/000050702

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  14 in total

1.  Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.

Authors:  Nikolaus Kohles; Dorothea Nagel; Dietrich Jüngst; Jürgen Durner; Petra Stieber; Stefan Holdenrieder
Journal:  Tumour Biol       Date:  2011-09-20

2.  Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival.

Authors:  Cesar Yaghi; Ala-I Sharara; Paul Rassam; Rami Moucari; Khalil Honein; Joseph BouJaoude; Rita Slim; Roger Noun; Heitham Abdul-Baki; Mohamad Khalifeh; Sami Ramia; Raymond Sayegh
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury.

Authors:  Yaqin Zhang; Linping Wu; Yang Wang; Mingcao Zhang; Limin Li; Dihan Zhu; Xihan Li; Hongwei Gu; Chen-Yu Zhang; Ke Zen
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

4.  Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population.

Authors:  Xue-E Xi; Yanqiong Liu; Yu Lu; Liying Huang; Xue Qin; Shan Li
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

5.  Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.

Authors:  Gabriele Kirchner; Georgi Kirovski; Alexandra Hebestreit; Jürgen Schölmerich; Hans Jürgen Schlitt; Oliver Stoeltzing; Claus Hellerbrand
Journal:  Int J Clin Exp Med       Date:  2010-06-10

Review 6.  Pathogenic interactions between alcohol and hepatitis C.

Authors:  Gyongyi Szabo
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 7.  Prevention of liver cancer.

Authors:  Kathryn Z Guyton; Thomas W Kensler
Journal:  Curr Oncol Rep       Date:  2002-11       Impact factor: 5.075

8.  Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.

Authors:  Robert Hanczko; David R Fernandez; Edward Doherty; Yueming Qian; Gyorgy Vas; Brian Niland; Tiffany Telarico; Adinoyi Garba; Sanjay Banerjee; Frank A Middleton; Donna Barrett; Maureen Barcza; Katalin Banki; Steve K Landas; Andras Perl
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

9.  Genetic polymorphisms in hypoxia-inducible factor-1a gene and its association with HBV-related hepatocellular carcinoma in a Chinese population.

Authors:  Yanqiong Liu; Jingzhe Sui; Limin Zhai; Shi Yang; Li Huang; Liying Huang; Cuiju Mo; Junrong Wu; Shan Li; Xue Qin
Journal:  Med Oncol       Date:  2014-09-07       Impact factor: 3.064

10.  Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis.

Authors:  Atsushi Kudo; Shinji Tanaka; Daisuke Ban; Satoshi Matsumura; Takumi Irie; Takanori Ochiai; Noriaki Nakamura; Shigeki Arii; Minoru Tanabe
Journal:  J Gastroenterol       Date:  2013-10-18       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.